Literature DB >> 20679346

Influence of apolipoprotein (Apo) A-I structure on nascent high density lipoprotein (HDL) particle size distribution.

Charulatha Vedhachalam1, Palaniappan Sevugan Chetty, Margaret Nickel, Padmaja Dhanasekaran, Sissel Lund-Katz, George H Rothblat, Michael C Phillips.   

Abstract

The principal protein of high density lipoprotein (HDL), apolipoprotein (apo) A-I, in the lipid-free state contains two tertiary structure domains comprising an N-terminal helix bundle and a less organized C-terminal domain. It is not known how the properties of these domains modulate the formation and size distribution of apoA-I-containing nascent HDL particles created by ATP-binding cassette transporter A1 (ABCA1)-mediated efflux of cellular phospholipid and cholesterol. To address this issue, proteins corresponding to the two domains of human apoA-I (residues 1-189 and 190-243) and mouse apoA-I (residues 1-186 and 187-240) together with some human/mouse domain hybrids were examined for their abilities to form HDL particles when incubated with either ABCA1-expressing cells or phospholipid multilamellar vesicles. Incubation of human apoA-I with cells gave rise to two sizes of HDL particles (hydrodynamic diameter, 8 and 10 nm), and removal or disruption of the C-terminal domain eliminated the formation of the smaller particle. Variations in apoA-I domain structure and physical properties exerted similar effects on the rates of formation and sizes of HDL particles created by either spontaneous solubilization of phospholipid multilamellar vesicles or the ABCA1-mediated efflux of cellular lipids. It follows that the sizes of nascent HDL particles are determined at the point at which cellular phospholipid and cholesterol are solubilized by apoA-I; apparently, this is the rate-determining step in the overall ABCA1-mediated cellular lipid efflux process. The stability of the apoA-I N-terminal helix bundle domain and the hydrophobicity of the C-terminal domain are important determinants of both nascent HDL particle size and their rate of formation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20679346      PMCID: PMC2952197          DOI: 10.1074/jbc.M110.126292

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  High density lipoprotein structure.

Authors:  Sissel Lund-Katz; Lijuan Liu; Stephen T Thuahnai; Michael C Phillips
Journal:  Front Biosci       Date:  2003-05-01

2.  The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo.

Authors:  Angeliki Chroni; Tong Liu; Irina Gorshkova; Horng-Yuan Kan; Yoshinari Uehara; Arnold Von Eckardstein; Vassilis I Zannis
Journal:  J Biol Chem       Date:  2002-12-17       Impact factor: 5.157

3.  The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux.

Authors:  Elda Favari; Franco Bernini; Patrizia Tarugi; Guido Franceschini; Laura Calabresi
Journal:  Biochem Biophys Res Commun       Date:  2002-12-20       Impact factor: 3.575

4.  Deletion of the C-terminal domain of apolipoprotein A-I impairs cell surface binding and lipid efflux in macrophage.

Authors:  J W Burgess; P G Frank; V Franklin; P Liang; D C McManus; M Desforges; E Rassart; Y L Marcel
Journal:  Biochemistry       Date:  1999-11-02       Impact factor: 3.162

5.  Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model.

Authors:  Hiroyuki Saito; Padmaja Dhanasekaran; David Nguyen; Paul Holvoet; Sissel Lund-Katz; Michael C Phillips
Journal:  J Biol Chem       Date:  2003-04-22       Impact factor: 5.157

6.  ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol.

Authors:  J F Oram; A M Vaughan; R Stocker
Journal:  J Biol Chem       Date:  2001-08-23       Impact factor: 5.157

Review 7.  Importance of different pathways of cellular cholesterol efflux.

Authors:  Patricia G Yancey; Anna E Bortnick; Ginny Kellner-Weibel; Margarita de la Llera-Moya; Michael C Phillips; George H Rothblat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-23       Impact factor: 8.311

8.  Structural and functional consequences of the Milano mutation (R173C) in human apolipoprotein A-I.

Authors:  Eric T Alexander; Masafumi Tanaka; Momoe Kono; Hiroyuki Saito; Daniel J Rader; Michael C Phillips
Journal:  J Lipid Res       Date:  2009-03-24       Impact factor: 5.922

9.  Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization.

Authors:  Mark L Segall; Padmaja Dhanasekaran; Faye Baldwin; G M Anantharamaiah; Karl H Weisgraber; Michael C Phillips; Sissel Lund-Katz
Journal:  J Lipid Res       Date:  2002-10       Impact factor: 5.922

10.  The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1.

Authors:  Stacey E Panagotopulos; Scott R Witting; Erica M Horace; David Y Hui; J Nicholas Maiorano; W Sean Davidson
Journal:  J Biol Chem       Date:  2002-08-13       Impact factor: 5.157

View more
  22 in total

1.  Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein.

Authors:  Timothy J Sontag; Ronald Carnemolla; Tomas Vaisar; Catherine A Reardon; Godfrey S Getz
Journal:  J Lipid Res       Date:  2012-03-08       Impact factor: 5.922

Review 2.  The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids.

Authors:  Guo-Jun Zhao; Kai Yin; Yu-Chang Fu; Chao-Ke Tang
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

3.  The roles of C-terminal helices of human apolipoprotein A-I in formation of high-density lipoprotein particles.

Authors:  Kohjiro Nagao; Mami Hata; Kento Tanaka; Yuki Takechi; David Nguyen; Padmaja Dhanasekaran; Sissel Lund-Katz; Michael C Phillips; Hiroyuki Saito
Journal:  Biochim Biophys Acta       Date:  2013-10-09

Review 4.  Is ABCA1 a lipid transfer protein?

Authors:  Michael C Phillips
Journal:  J Lipid Res       Date:  2018-01-05       Impact factor: 5.922

Review 5.  Update on HDL receptors and cellular cholesterol transport.

Authors:  Ginny Kellner-Weibel; Margarita de la Llera-Moya
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

Review 6.  New insights into the determination of HDL structure by apolipoproteins: Thematic review series: high density lipoprotein structure, function, and metabolism.

Authors:  Michael C Phillips
Journal:  J Lipid Res       Date:  2012-12-10       Impact factor: 5.922

7.  Folded functional lipid-poor apolipoprotein A-I obtained by heating of high-density lipoproteins: relevance to high-density lipoprotein biogenesis.

Authors:  Shobini Jayaraman; Giorgio Cavigiolio; Olga Gursky
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

8.  Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL.

Authors:  Xuan Gao; Shujun Yuan; Shobini Jayaraman; Olga Gursky
Journal:  Biochemistry       Date:  2012-06-01       Impact factor: 3.162

9.  Crystal structure of Δ(185-243)ApoA-I suggests a mechanistic framework for the protein adaptation to the changing lipid load in good cholesterol: from flatland to sphereland via double belt, belt buckle, double hairpin and trefoil/tetrafoil.

Authors:  Olga Gursky
Journal:  J Mol Biol       Date:  2012-10-04       Impact factor: 5.469

Review 10.  ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease.

Authors:  Dimitry A Chistiakov; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Lab Invest       Date:  2016-05-16       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.